Blossom keeps close track of new psychedelic research to keep you up-to-date. In cooperation with Psychedelic Alpha, we publish a monthly overview that recaps the latest research in one article. All papers that didn’t make the cut are featured in our handy link overviews.
In October we investigate discontinuation of antidepressants and psychedelic treatments, 2C-B effects, and neurofeedback and psychedelics.
Psychedelic research in September 2024 covered mescaline dosing, meditation, psilocybin for veterans, harmine dosing, and more
The psychedelic research from July and August 2024. Covering LSD follow-up, R vs S-MDMA, and false insights after psychedelics.
Psychedelic research in June 2024 investigated the coupling of psychedelics (and benzos), the role of purging, and ethical guidelines
Psychedelic research in May 2024 investigates awe in ketamine therapy, role of therapy in PAT, touch guidelines, real world impact of psychedelics, and more.
April 2024 psychedelic research explores mechanisms, addresses challenges, compares MDMA to amphetamines, reviews 5-MeO-DMT, and investigates novel therapeutic applications for seizures, personality disorders, and cluster headaches.
In this recap of the latest psychedelic research from March 2024 we look at meditation, SSRIs, and safety of psychedelics, and 17 more studies.
What happens if psychedelics become a regular part of therapy? In a way, that is what the majority of research on psychedelics is trying to answer. Studies analysing the safety, to mapping out the effectiveness in various domains, including those featured here in February, help us understand psychedelics as medicines.
January saw new psychedelic trials on ibogaine for TBI, DMT, and psilocybin for CCHs, alongside re-analyses on psychedelic brain impacts, therapy dynamics in MDMA treatment, and LSD visuals. Studies also probed SSRI-psychedelic interactions, expectancy roles, and heart effects from microdosing.
December's psychedelic research (2023) looked at group therapy, personality, costs and microdosing LSD. We added 22 articles to the database.
Research Briefings
At Blossom, we start our day by gathering the latest psychedelic research. Our inbox receives the latest from PubMed, psyarxiv, Google Scholar, and the many other sources where new research is being published.
In the monthly recap, now running for over 2 years, we bring together this deluge of information in an easy to understand format.
All papers that haven’t made the cut are still archived in our link overviews.
